Co-Diagnostics, Inc. Common Stock

CODXNASDAQ • USD
1.15 USD
↗ 0.05 (4.55%)AT CLOSE (03:59 PM EDT)
1.14
↘ 0.01 (1.30%)
POST MARKET (AS OF 06:05 PM EDT)
Post Market
AS OF 06:05 PM EDT
1.14
↘ 0.01 (1.30%)
🟢Market: OPEN

Co-Diagnostics, Inc. Common Stock (CODX) is currently trading at $1.14. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place CODX at a fair price relative to peers.

Technical & fundamental data as of Oct 6, 2026.

Open?$1.12
High?$1.17
Low?$1.05
Prev. Close?$1.10
Volume?886.5K
Avg. Volume?252.0K
VWAP?$1.11
Rel. Volume?3.52x
Bid / Ask
Bid?$0.96 × 100
Ask?$1.30 × 100
Spread?$0.34
Midpoint?$1.13
Valuation & Ratios
Market Cap?7.7M
Shares Out?7.0M
Float?5.2M
Float %?97.7%
P/E Ratio?N/A
P/B Ratio?0.60
EPS?-$6.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Employees
115
Market Cap
7.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2017-07-12
Address
2401 S FOOTHILL DRIVE
SALT LAKE CITY, UT 84109
Phone: (801) 438-1036
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
77
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-16.42Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.92%Elevated
Short Interest?305.0K
Days to Cover?2.4
Free Float5.2M
Avg Daily Volume130.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.81Adequate
Quick Ratio?1.52Adequate
Cash Ratio?1.27Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.60CHEAP▾
P/S?
Peers
100
S&P
7
10.65HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
Peers
100
S&P
31
5.59FAIR▾
Returns & Efficiency
ROE?
S&P
3
-370.2%WEAK▾
ROA?
S&P
3
-283.6%WEAK▾
Cash Flow & Enterprise
FCF?$-27470575
Enterprise Value?$4.0M
Fundamentals ratios updated end of day